Insights

Access our latest insights & resources

Filters

Content Type: Research

Global U.S. Banks: Q4 2023 Earnings Preview

Global U.S. Banks: Q4 2023 Earnings Preview

Research, Fundamental
Global US banks may have weak Q4 comps.
Read more
Lowry Special Report From Unloved to Exuberant: Medium-Term Momentum Reversals

Lowry Special Report From Unloved to Exuberant: Medium-Term Momentum Reversals

Research, Technical
Media commentators use "market momentum" to describe the enthusiasm...
Read more
Lowry Weekly ETF Commentary – January 05, 2024

Lowry Weekly ETF Commentary – January 05, 2024

Research, Technical
Despite the stock market's turbulent beginning to the new year, some...
Read more
Lowry Weekly Sector Commentary- January 03, 2024

Lowry Weekly Sector Commentary- January 03, 2024

Research, Technical
Lowry's core indicators now support a healthier investing environment.
Read more
2024 Technology Hardware/Storage Outlook

2024 Technology Hardware/Storage Outlook

Research, Fundamental
The technology hardware industry has faced numerous challenges in the...
Read more
Drug Distributors: Prescription Volumes, New Therapies Powering Higher Stock Prices

Drug Distributors: Prescription Volumes, New Therapies Powering Higher Stock Prices

Research, Fundamental
Drug distributors MCK, COR, and CAH have been performing significantly...
Read more
ETF Trends to Watch in 2024: Part 2

ETF Trends to Watch in 2024: Part 2

Research, Other
As the U.S. ETF industry crosses the $8 trillion asset threshold to...
Read more
European Maritime Logistics: Overcapacity and Subdued Demand Sink Freight Rates

European Maritime Logistics: Overcapacity and Subdued Demand Sink Freight Rates

Research, Fundamental
Maritime logistics are grappling with a new reality characterized by plummeting market freight...
Read more
Consumer Staples: Risks From Anti-Obesity Medications Likely Overblown

Consumer Staples: Risks From Anti-Obesity Medications Likely Overblown

Research, Fundamental
Anti-obesity medications (AOMs), including glucagon-like peptide-1 (GLP-1) agonists...
Read more
Amazon: $7+ EPS by 2025 Could Be the Next Catalyst

Amazon: $7+ EPS by 2025 Could Be the Next Catalyst

Research, Fundamental
Wall Street has historically valued AMZN shares using nontraditional relative valuation metrics.
Read more